Clinical Trial - Scientist - Cancer - Melanoma - Chemotherapy
Talent Online
0:00
36
2
Description
Vocal Characteristics
Language
EnglishVoice Age
Middle Aged (35-54)Accents
North American (General)Transcript
Note: Transcripts are generated using speech recognition software and may contain errors.
Let's take a closer look at the columbus trial. In this trial, 577 patients with BRAF V. 600 E. Or V 600 K mutation positive, unrestricted or metastatic melanoma, most of whom were treatment naive, were randomly assigned to receive either and crafted, plus been imatinib and crafted monotherapy or VM. You're offended monotherapy. The primary endpoint was a comparison of the progression free survival of end craft and it plus been imatinib versus ventura fine nib.